Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To evaluate the humoral response to and impact of SARS-CoV-2 vaccination in patients with systemic lupus erythematosus in a multicenter cohort design.
Methods: Data for this analysis were obtained from the Study of Safety, Effectiveness and Duration of Immunity after Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Inflammatory Diseases (SAFER), a prospective, multicenter, phase IV, real-world study conducted across different regions of Brazil from June/2021 to March/2024. Patients aged >18 years with systemic lupus erythematosus (SLE) who received any one of the SARS-CoV-2 vaccines approved by the Brazilian health regulatory agency (CoronaVac [inactivated SARS-CoV-2 vaccine], ChAdOx-1 [AstraZeneca], or BNT162b2 [Pfizer-BioNTech]) were included. Immunogenicity was assessed in pre- and post-vaccination blood samples, and patients were monitored in person and remotely for the occurrence and severity of COVID-19.
Results: Two hundred and thirty-five patients with SLE who had completed their vaccination schedules (two doses + booster dose) were included in this study. Most patients were female (89.3%) and had low disease activity or were in remission (72.4%); the majority were also on some form of immunosuppressive therapy (58.1%). One hundred and sixteen patients received two doses of CoronaVac followed by one dose of BNT162b2 (Pfizer-BioNTech) vaccine, eighty-seven received two doses of ChAdOx1-S (AstraZeneca) followed by one dose of BNT162b2 (Pfizer-BioNTech) vaccine, and thirty-two received three doses of BNT162b2 (Pfizer-BioNTech) vaccine. Twenty-eight cases of COVID-19, none meeting criteria for severe COVID-19, were recorded in patients with respiratory symptoms after the second dose of a SARS-CoV-2 vaccine. Regarding immunogenicity, an increase in seroconversion rate was observed following consecutive vaccine doses, with no difference between vaccination schedules, reaching 97.57% seropositivity after a booster dose. The geometric mean IgG titers differed between the different vaccination schedules after the first and the second vaccine dose, being lowest for the CoronaVac-based schedule, but titers were similar after the administration of a booster dose.
Conclusion: In patients with SLE, SARS-CoV-2 vaccines are immunogenic, inducing a robust humoral response. No severe outcomes associated with death or hospitalization were found in the evaluated patient sample. Complete vaccination schedules including a booster dose induced higher humoral responses than incomplete schedules, especially in patients initially immunized with an inactivated virus vaccine schedule and those with a suboptimal humoral response.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11861989 | PMC |
| http://dx.doi.org/10.3390/vaccines13020127 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vaccine Immunity Against Pneumococcus in Children With Sickle Cell Disease: A Retrospective Single-center Study.
Pediatr Infect Dis J
September 2025
Division of General Pediatrics, Department of Pediatrics, Gynecology and Obstetrics, Unit of Immunology, Vaccinology, and Rheumatology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Background And Aims: Sickle cell disease (SCD) patients are at a higher risk of pneumococcal invasive diseases. Vaccination is the central strategy for protecting these children, along with penicillin prophylaxis. However, it is unclear how often these children should be revaccinated with pneumococcal vaccines.
View Article and Find Full Text PDFAttitudes to malaria vaccination in children: what can be learned from their consistency with the temporal dynamics of COVID-19 vaccination intention? A prospective cohort study in rural Senegal (July 2020-November 2023).
BMJ Glob Health
September 2025
Aix-Marseille Univ, IRD, SSA, MINES, Marseille, France.
Introduction: Several sub-Saharan African countries are launching malaria vaccination programmes for children. We assessed how attitudes to malaria vaccination for children could be better understood by considering the individual dynamics of COVID-19 vaccine intention/uptake over the 2021-2023 campaigns, with a view to highlighting barriers likely to affect malaria vaccine uptake.
Methods: We conducted a six-wave telephone-based survey of 600 randomly selected Senegalese households.
Simulation-based assessment of digital twin systems for immunisation.
Front Digit Health
August 2025
FEN - Graduate School in Engineering, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Background: This paper presents the application of simulation to assess the functionality of a proposed Digital Twin (DT) architecture for immunisation services in primary healthcare centres. The solution is based on Industry 4.0 concepts and technologies, such as IoT, machine learning, and cloud computing, and adheres to the ISO 23247 standard.
View Article and Find Full Text PDFDeterminants of vaccination coverage during the COVID-19 pandemic among children aged 12-23 months in southern Ethiopia: a cross-sectional study.
Front Pediatr
August 2025
Department of Pediatrics and Child Health Nursing, Wachemo University, Hosanna, Ethiopia.
Background: Millions of children, particularly in low and middle-income countries, are deprived of a comprehensive vaccination schedule. The advent of the COVID-19 pandemic exacerbated this issue by significantly disrupting vaccination schedules and other critical health initiatives. In light of this challenge, our study sought to evaluate vaccination coverage and identify its determinants among children aged 12-23 months in southern Ethiopia during the COVID-19 pandemic.
View Article and Find Full Text PDFParental Perspectives on Childhood Vaccination: Analysing Knowledge and Attitudes Among Families in Tabuk, Saudi Arabia.
Patient Prefer Adherence
September 2025
Family and Community Medicine Department, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi Arabia.
Purpose: To ascertain the knowledge and attitudes of parents on childhood vaccination in Tabuk, Saudi Arabia, as well as their perceived barriers to vaccination.
Patients And Methods: Three hundred and thirty parents were selected in this cross-sectional study by convenience sampling from the parents who attended several primary healthcare facilities to vaccinate their children. A pre-made questionnaire was used, which included the sociodemographic characteristics and questions about the parents' knowledge, attitude toward childhood vaccination, and compliance with vaccination according to the immunization schedule.